Page 359

House Bill No. 5506

Public Act No. 22-118 359 of 739

(D) Information obtained from the all-payer claims database established under section 19a-755a of the general statutes; and (E) Any other information that the executive director, in the executive director's discretion, deems relevant for the purposes of this section. (2) The executive director shall account for costs, net of rebates and discounts, when identifying other entities pursuant to this section. Sec. 222. (NEW) (Effective from passage) (a) (1) Not later than June 30, 2023, and annually thereafter, the executive director shall hold an informational public hearing to compare the growth in total health care expenditures in the performance year to the health care cost growth benchmark established pursuant to section 219 of this act for such year. Such hearing shall involve an examination of: (A) The report most recently prepared by the executive director pursuant to subsection (b) of section 220 of this act; (B) The expenditures of provider entities and payers, including, but not limited to, health care cost trends, primary care spending as a percentage of total medical expenses and the factors contributing to such costs and expenditures; and (C) Any other matters that the executive director, in the executive director's discretion, deems relevant for the purposes of this section. (2) The executive director may require any payer or provider entity that, for the performance year, is found to be a significant contributor to health care cost growth in the state or has failed to meet the primary care spending target, to participate in such hearing. Each such payer or provider entity that is required to participate in such hearing shall provide testimony on issues identified by the executive director and provide additional information on actions taken to reduce such payer's or entity's contribution to future state-wide health care costs and